Click to Return to Search Page VIEW SELECTED LIBRARY MEDIA Name of Media: Making an Emotional Recovery Together In the COVID-19 ICU Author(s): Ethan Lester, Ph.D. Publisher or Source: Psychology Today Type of Media: Magazine Article Media Originally for: General Public,General Medical Professionals Country of Origin: United States of America (the) Primary Focus of Media: Post Intensive Care Syndrome (PICS) COVID-19 Related: Yes Description: This post is Part 2 of a series on ICU trauma and how to cope. Read Part 1 here: The Psychological Trauma of Having a Loved One in the ICU, by Maureen O'Reilly-Landry, Ph.D. Read Part 3 here: Managing Emotional Distress in the Hospital and ICU by Ethan Lester, Ph.D. Read Part 4 here: What Can I Do if My Family Member is in the COVID ICU? by Irina Wen, Ph.D. This post describes a program created prior to COVID that has been helping ICU patients and their families to cope. The symptoms of COVID-19 are often serious and can produce lasting physical and psychological impact. For those patients hospitalized, more than half of them require assistance with oxygen due to difficulties breathing, and those who continue to decline require admission to an intensive care unit (ICU). Critical care hospitalizations are known to produce heightened emotional distress (depression, anxiety, post-traumatic stress) in both patients and families (described as post-intensive care syndrome); and may persist long after ICU discharge. To view the PDF, Article, Photo, or Chart, Click Icon: To view the attached Video media file, Click Icon: PostICU, Inc's library staff reviewed this copyrighted material contained in the library and reasonably believes that its inclusion in our library complies with the "Fair Use Doctrine" because: (1) our library's is for nonprofit and educational purposes; (2) the nature of the copyrighted work is related to our mission; (3) the amount and substantiality of the portion used in relation to the copyrighted work as a whole is fair and reasonable; and (4) the potential market for or value of the copyrighted work will if impacted, should be enhanced, by its presence in our library.

There’s Nothing Here... We can’t find the page you’re looking for. Check the URL, or head back home. Go Home

There’s Nothing Here... We can’t find the page you’re looking for. Check the URL, or head back home. Go Home

There’s Nothing Here... We can’t find the page you’re looking for. Check the URL, or head back home. Go Home

There’s Nothing Here... We can’t find the page you’re looking for. Check the URL, or head back home. Go Home

There’s Nothing Here... We can’t find the page you’re looking for. Check the URL, or head back home. Go Home

Click to Return to Search Page VIEW SELECTED LIBRARY MEDIA Name of Media: UK study to research vitamin D coronavirus link Author(s): Arab News Publisher or Source: Arab News Type of Media: Newspaper Article Media Originally for: General Public Country of Origin: Saudi Arabia Primary Focus of Media: Post Intensive Care Syndrome (PICS) COVID-19 Related: Yes Description: LONDON: A UK university is launching a major study into the potential link between vitamin D and protection against coronavirus. To view the PDF, Article, Photo, or Chart, Click Icon: To view the attached Video media file, Click Icon: PostICU, Inc's library staff reviewed this copyrighted material contained in the library and reasonably believes that its inclusion in our library complies with the "Fair Use Doctrine" because: (1) our library's is for nonprofit and educational purposes; (2) the nature of the copyrighted work is related to our mission; (3) the amount and substantiality of the portion used in relation to the copyrighted work as a whole is fair and reasonable; and (4) the potential market for or value of the copyrighted work will if impacted, should be enhanced, by its presence in our library.

Click to Return to Search Page VIEW SELECTED LIBRARY MEDIA Name of Media: Evaluating clinical pharmacist involvement in a COVID-19 intensive care recovery clinic Author(s): Stephen Ward, Rosalind O'Reilly, and Paula Crawford Publisher or Source: The Pharmaceutical Journal Type of Media: Medical Journal Media Originally for: Critical Care Physicians,General Medical Professionals,Nurses and/or Other Critical Care Medical Professionals Country of Origin: United Kingdom of Great Britain and Northern Ireland (the) Primary Focus of Media: Post Intensive Care Syndrome (PICS) COVID-19 Related: Yes Description: Introduction: Post-intensive care syndrome (PICS) is associated with an increased risk of mortality. Critical illness recovery clinics have been recommended by the Faculty of Intensive Care Medicine (FICM) as an approach to manage the complexity of PICS. The COVID-19 pandemic has provided many healthcare challenges, not least how to support those who have survived critical illness related to the virus. Recent guidance from the FICM also recommends pharmacist involvement in rehabilitation and recovery clinics for patients discharged from hospital following COVID-19 critical illness. This evaluation was undertaken to determine the impact of the inclusion of a clinical pharmacist in this setting. Method: All patients discharged following a COVID-19-related intensive care unit (ICU) admission in the Belfast Health and Social Care Trust, Northern Ireland, from 26 March 2020 to 15 May 2020 were offered enrolment in a rehabilitation and recovery programme. This involved an initial 6-week remote review, followed by a multidisciplinary face-to-face assessment at 12 weeks post-discharge. Each healthcare professional at the clinic contributed to an overall treatment plan, which was communicated to the patient’s GP. The clinical pharmacist carried out a structured medicines optimisation review and identified medication-related interventions, which were recorded and graded according to the Eadon criteria. Cost savings resulting from these interventions were estimated using the model described by the University of Sheffield School of Health and Related Research (ScHARR), a type of economic modelling that uses literature-based values of the costs of medication errors and compares this with the benefits of different medication-related interventions. Results: A total of 42 patients were discharged during this period following COVID-19 ICU admission, with 93% (n=39) agreeing to enrolment in the follow-up clinic. Medication-related interventions were identified in 82% (n=32) of the 39 patients. The most common medication-related intervention was patient education, accounting for 38% (n=24) of all interventions. Discussion: Analgesics were the class of medications most associated with requiring an intervention and 65% of interventions were graded as significant, resulting in improved care standards (i.e. Eadon ≥grade 4). Clinical pharmacist interventions yielded potential savings of £4.20–£8.59 per £1 invested, based on total potential savings in the range of £6,204–£12,699, with a total pharmacist investment of £1,478. Conclusion: Clinical pharmacists have a role in medicines optimisation for patients recovering from COVID-19-related critical illness. Most interventions by a clinical pharmacist in a post-ICU recovery clinic were related to symptom management and patient education. Their role in this setting can help rationalise medicines and improve patients’ understanding, resulting in potential healthcare-related cost-savings and safer patient-centred care. Keywords: Clinical pharmacy, COVID-19, critical care, integrated care, intensive care, interventions, medicines optimisation, outpatient clinic. To view the PDF, Article, Photo, or Chart, Click Icon: To view the attached Video media file, Click Icon: PostICU, Inc's library staff reviewed this copyrighted material contained in the library and reasonably believes that its inclusion in our library complies with the "Fair Use Doctrine" because: (1) our library's is for nonprofit and educational purposes; (2) the nature of the copyrighted work is related to our mission; (3) the amount and substantiality of the portion used in relation to the copyrighted work as a whole is fair and reasonable; and (4) the potential market for or value of the copyrighted work will if impacted, should be enhanced, by its presence in our library.

There’s Nothing Here... We can’t find the page you’re looking for. Check the URL, or head back home. Go Home

There’s Nothing Here... We can’t find the page you’re looking for. Check the URL, or head back home. Go Home

Click to Return to Search Page VIEW SELECTED LIBRARY MEDIA Name of Media: Assessment of a new self-rating scale for post-traumatic stress disorder Author(s): J. R. T. DAV IDSON," S. W. BOOK, J. T. COLKET, L. A. TUPLER, S. ROTH, D. DAV ID, M. HERTZBERG, T. MELLMAN, J. C. BECKHAM, R. D. SM ITH, R. M. DAV ISON, R. KATZ M. E. FELDMAN Publisher or Source: Psychological Medicine Type of Media: Medical Journal Media Originally for: Critical Care Physicians, General Medical Professionals, Nurses and/or Other Critical Care Medical Professionals Country of Origin: United States Primary Focus of Media: Post Traumatic Stress Disorder (PTSD) COVID-19 Related: No Description: Background. In post-traumatic stress disorder (PTSD) there is a need for self-rating scales that are sensitive to treatment effects and have been tested in a broad range of trauma survivors. Separate measures of frequency and severity may also provide an advantage. Methods. Three hundred and fifty-three men and women completed the Davidson Trauma Scale (DTS), a 17-item scale measuring each DSM-IV symptom of PTSD on 5-point frequency and severity scales. These subjects comprised war veterans, survivors of rape or hurricane and a mixed trauma group participating in a clinical trial. Other scales were included as validity checks as follows: Global ratings, SCL-90-R, Eysenck Scale, Impact of Event Scale and Structured Clinical Interview for DSM-III-R. Results. The scale demonstrated good test–retest reliability (r ̄0±86), internal consistency (r ̄0±99). One main factor emerged for severity and a smaller one for intrusion. In PTSD diagnosed subjects, and the factor structure more closely resembled the traditional grouping of symptoms. Concurrent validity was obtained against the SCID, with a diagnostic accuracy of 83% at a DTS score of 40. Good convergent and divergent validity was obtained. The DTS showed predictive validity against response to treatment, as well as being sensitive to treatment effects. Conclusions. The DTS showed good reliability and validity, and offers promised as a scale which is particularly suited to assessing symptom severity, treatment outcome and in screening for the likely diagnosis of PTSD. To view the PDF, Article, Photo, or Chart, Click Icon: To view the attached Video media file, Click Icon: PostICU, Inc's library staff reviewed this copyrighted material contained in the library and reasonably believes that its inclusion in our library complies with the "Fair Use Doctrine" because: (1) our library's is for nonprofit and educational purposes; (2) the nature of the copyrighted work is related to our mission; (3) the amount and substantiality of the portion used in relation to the copyrighted work as a whole is fair and reasonable; and (4) the potential market for or value of the copyrighted work will if impacted, should be enhanced, by its presence in our library.

There’s Nothing Here... We can’t find the page you’re looking for. Check the URL, or head back home. Go Home